Shandong Bailong Chuangyuan Bio-tech Co.,Ltd (hereinafter referred to as "the Company") recently received an invention patent certificate issued by the European Patent Office. The specific details are as follows:
Patent Name: Bacillus subtilis strain, culture method and application thereof
European Patent No.: EP3550011
Authorization Date: March 12, 2025
Valid Countries: Belgium, Germany, Spain, France, the United Kingdom, Italy, the Netherlands, Portugal, Sweden, Turkey (Unitary Patent Route + Traditional Route)
Validity Period: 20 years
The Company owns 8 provincial-level and above R&D platforms including a national postdoctoral workstation and the China National Light Industry Dietary Fiber Engineering Technology Research Center, forming an innovation system integrating experiments, small-scale trials, pilot-scale tests and industrialization. It has established long-term industry-university-research cooperation relations with scientific research institutes such as Shandong University, Jiangnan University, Shandong Academy of Agricultural Sciences and Qilu University of Technology.
The Company has successively undertaken more than 10 key R&D projects at the provincial level and above, including 5 national key R&D programs and 5 provincial key R&D programs. At present, the Company has obtained 87 invention patent authorizations (77 domestic invention patents and 10 international invention patents); among them, there are 14 invention patents related to allulose, including 6 international patents (3 US patents, 2 Canadian patents and 1 European patent).
The authorization of the European patent is an international recognition of Bailong Chuangyuan's scientific research strength and innovative achievements. It not only means that the technology has obtained legal protection in the European market, but also demonstrates Bailong Chuangyuan's competitiveness in the global microbial technology field. It will encourage Bailong Chuangyuan to continue increasing R&D investment, keep exploring and innovating, and contribute more wisdom and strength to the development of the industry. Now,our company specializes in the following product lines: Dietary Fiber Series, Prebiotics Series, and Other Starch Sugar(alcohol) Series.
In the future, taking this patent authorization as an opportunity, Bailong Chuangyuan will further deepen industry-university-research cooperation, accelerate the transformation of scientific and technological achievements, continue to deepen its layout in microbial technology and related fields, and contribute more to promoting industry progress and improving human health!
